Literature DB >> 16766471

Preparation and characterization of metoprolol controlled-release solid dispersions.

Jaleh Varshosaz1, Hossein Faghihian, Kobra Rastgoo.   

Abstract

In recent years, great attention has been paid to using solid dispersions to make sustained-release drugs. The objective of this study is to produce sustained-release systems of metoprolol tartrate using solid dispersion techniques and to evaluate their physicochemical characteristics. The solid dispersions were produced by melting and solvent methods, containing 7%, 15%, or 25% of the drug and different ratios of Eudragit RLPO and RSPO in ratios of 0:10, 3:7, 5:5, 7:3, and 10:0. Drug release profiles were determined by USP XXIII rotating paddle method in phosphate buffer solution (pH 6.8). XRD, DSC, IR, and microscopic observations were performed to evaluate the physical characteristics of solid dispersions. Results showed that the drug release from dispersions was at a slower rate than pure drug and physical mixtures. Moreover, the formulations containing greater ratios of Eudragit RSPO showed slower release rates and smaller DE8% but larger mean dissolution time than those containing greater ratios of Eudragit RLPO. Dispersions with particle size of less than 100 microm containing 7% of metoprolol and Eudragit RL:RS 5:5 (solvent method) and those with the ratio of 3:7 (melting method) had similar release pattern to Lopressor sustained-release tablets by zero-order and Higuchi kinetics, respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16766471     DOI: 10.1080/10717540500459308

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.419


  4 in total

Review 1.  Controlled release systems containing solid dispersions: strategies and mechanisms.

Authors:  Phuong Ha-Lien Tran; Thao Truong-Dinh Tran; Jun Bom Park; Beom-Jin Lee
Journal:  Pharm Res       Date:  2011-05-07       Impact factor: 4.200

2.  Compatibility and stability studies involving polymers used in fused deposition modeling 3D printing of medicines.

Authors:  Ihatanderson A Silva; Ana Luiza Lima; Tais Gratieri; Guilherme M Gelfuso; Livia L Sa-Barreto; Marcilio Cunha-Filho
Journal:  J Pharm Anal       Date:  2021-09-20

3.  Sustained release ivermectin-loaded solid lipid dispersion for subcutaneous delivery: in vitro and in vivo evaluation.

Authors:  Mengmeng Lu; Dan Xiong; Weiwei Sun; Tong Yu; Zixia Hu; Jiafeng Ding; Yunpeng Cai; Shizhuang Yang; Baoliang Pan
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

4.  Cardioprotective effects of a novel hydrogen sulfide agent-controlled release formulation of S-propargyl-cysteine on heart failure rats and molecular mechanisms.

Authors:  Chengrong Huang; Juntao Kan; Xu Liu; Fenfen Ma; Ba Hieu Tran; Yunzeng Zou; Shujun Wang; Yi Zhun Zhu
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.